机构

• 上海药物研究所 [11]

采集方式

• OAI收割 [11]

内容类型

• 期刊论文 [11]

发表日期

• 2023 [2]
• 2022 [3]
• 2021 [5]

学科主题

筛选

浏览/检索结果: 共11条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Targeting C/EBP alpha overcomes primary resistance and improves the efficacy of FLT3 inhibitors in acute myeloid leukaemia 期刊论文  OAI收割 NATURE COMMUNICATIONS, 2023, 卷号: 14, 期号: 1, 页码: 18 作者:  Wang, Hanlin;  Luo, Guanghao;  Hu, Xiaobei;  Xu, Gaoya;  Wang, Tao   |  收藏  |  浏览/下载：12/0  |  提交时间：2023/10/17 Phosphorylation of PHF2 by AMPK releases the repressive H3K9me2 and inhibits cancer metastasis 期刊论文  OAI收割 Signal Transduction and Targeted Therapy, 2023, 卷号: 8, 期号: 4, 页码: 1857-1873 作者:  Dong, Ying;  Hu, Hao;  Zhang, Xuan;  Zhang, Yunkai;  Sun, Xin   |  收藏  |  浏览/下载：12/0  |  提交时间：2024/03/27 Discovery of Novel N-(5-(Pyridin-3-yl)-1H-indazol-3-yl)benzamide Derivatives as Potent Cyclin-Dependent Kinase 7 Inhibitors for the Treatment of Autosomal Dominant Polycystic Kidney Disease 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2022, 页码: 19 作者:  Yang, Bowen;  Zhang, Haoran;  Li, Na;  Gao, Lixin;  Jiang, Hong   |  收藏  |  浏览/下载：20/0  |  提交时间：2023/04/10 Structural Feature Analyzation Strategies toward Discovery of Orally Bioavailable PROTACs of Bruton's Tyrosine Kinase for the Treatment of Lymphoma 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 65, 期号: 13, 页码: 9096–9125 作者:  Zhang, Jingyu;  Che, Jinxin;  Luo, Xiaomin;  Wu, Mingfei;  Kan, Weijuan   |  收藏  |  浏览/下载：16/0  |  提交时间：2024/03/21 Structure-Activity Relationship Study of Indolin-5-yl-cyclopropanamine Derivatives as Selective Lysine Specific Demethylase 1 (LSD1) Inhibitors 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 65, 期号: 5, 页码: 4335-4349 作者:  Li, Chunpu;  Su, Mingbo;  Zhu, Wei;  Kan, Weijuan;  Ge, Tianpeng   |  收藏  |  浏览/下载：31/0  |  提交时间：2022/06/15 Inner nuclear membrane protein TMEM201 promotes breast cancer metastasis by positive regulating TGF beta signaling 期刊论文  OAI收割 ONCOGENE, 2021, 页码: 10 作者:  Kong, Ya;  Zhang, Yutian;  Wang, Hanlin;  Kan, Weijuan;  Guo, Haoran   |  收藏  |  浏览/下载：35/0  |  提交时间：2022/01/04 Discovery and Development of a Potent, Selective, and Orally Bioavailable CHK1 Inhibitor Candidate: 5-((4-((3-Amino-3-methylbutyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)picolinonitrile 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 64, 期号: 20, 页码: 15069-15090 作者:  Jin, Tingting;  Xu, Lei;  Wang, Peipei;  Hu, Xiaobei;  Zhang, Runyuan   |  收藏  |  浏览/下载：27/0  |  提交时间：2022/01/04 Discovery of Potent and Selective CDK9 Degraders for Targeting Transcription Regulation in Triple-Negative Breast Cancer 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 64, 期号: 19, 页码: 14822-14847 作者:  Wei, Dan;  Wang, Hanlin;  Zeng, Qinghe;  Wang, Wenjing;  Hao, Bingbing   |  收藏  |  浏览/下载：45/0  |  提交时间：2021/12/16 Rational Design and Development of Novel CDK9 Inhibitors for the Treatment of Acute Myeloid Leukemia 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 64, 期号: 19, 页码: 14647-14663 作者:  Han, Xu;  Song, Ning;  Saidahmatov, Abdusaid;  Wang, Peipei;  Wang, Yong   |  收藏  |  浏览/下载：58/0  |  提交时间：2021/12/16 Design, synthesis and biological evaluation of thioether-containing lenalidomide and pomalidomide derivatives with anti-multiple myeloma activity 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 209, 页码: 13 作者:  Wang, Yuhong;  Mi, Tian;  Li, Yiming;  Kan, Weijuan;  Xu, Gaoya   |  收藏  |  浏览/下载：16/0  |  提交时间：2021/05/24 Lenalidomide  Multiple myeloma  MM.1S  Late-stage sulfuration